SCHEMBL9759416

SCHEMBL9759416

CCCCCNc1cccc2c1CCCC2

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
MEN1 O00255 1/20 0.57
THRA P10827 1/20 0.57
THRB P10828 1/20 0.57
KMT2A Q03164 1/20 0.57
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
HDAC6 Q9UBN7 2/20 0.46
ACHE P22303 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
METAP2 P50579 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13256427 0.89 ALDH1A1 (0.61) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL18893376 0.85 ALDH1A1 (0.57) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL11935623 0.84 HTT (0.51) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL8166642 0.82 HTT (0.58) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL8887849 0.80 HTT (0.56) ALDH1A1LMNAMEN1THRATHRB
Hydrochloric Acid SCHEMBL9850654 0.79 HTT (0.55) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL13564923 0.78 ALDH1A1 (0.45) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL11941134 0.78 GRIA1 (0.47) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL12471303 0.78 HTT (0.54) ALDH1A1LMNAMEN1THRATHRB
SCHEMBL30203895 0.78 NPC1 (0.50) ALDH1A1LMNAMEN1THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5047422-A Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract BAYER AKTIENGESELLSCHAFT (DE) 1991-09-10 US disclosed
US-4968679-A DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
US-4873262-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1989-10-10 US disclosed
EP-0272534-A2 8-substituted 2-aminotetralins BAYER AG (DE) 1988-06-29 EP disclosed